Despite advances in acute management and prevention of cerebrovascular disease, stroke
and vascular cognitive impairment together remain the world's leading cause of death and …

Hypertension is a frequent condition encountered during kidney disease development and a
leading cause in its progression. Hallmark factors contributing to hypertension constitute a …

Background Endovascular renal denervation reduces blood pressure in patients with mild-to-
moderate hypertension, but its efficacy in patients with true resistant hypertension has not …

Background Catheter-based renal denervation has significantly reduced blood pressure in
previous studies. Following a positive pilot trial, the SPYRAL HTN-OFF MED (SPYRAL …

Summary Background The SYMPLICITY HTN-3 (Renal Denervation in Patients With
Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system …

Background Conflicting blood pressure-lowering effects of catheter-based renal artery
denervation have been reported in patients with resistant hypertension. We compared the …

Importance Limited evidence suggests exercise reduces blood pressure (BP) in individuals
with resistant hypertension, a clinical population with low responsiveness to drug therapy …

It has been almost 5 years since the publication of the 2010 hypertension guidelines of the
Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of …

Few data are available with regard to the effectiveness of renal sympathetic denervation in
patients with resistant hypertension yet only mildly elevated blood pressure (BP). Patients …

Background: Results of the SYMPLICITY HTN-3 (Renal Denervation in Patients With
Uncontrolled Hypertension) trial confirmed the safety but not the efficacy of renal …